Amantadine Inhibits SARS-CoV-2 In Vitro
Since the SARS-CoV-2 pandemic started in late 2019, the search for protective vaccines and for drug treatments has become mandatory to fight the global health emergency. Travel restrictions, social distancing, and face masks are suitable counter measures, but may not bring the pandemic under control...
Main Authors: | Klaus Fink, Andreas Nitsche, Markus Neumann, Marica Grossegesse, Karl-Heinz Eisele, Wojciech Danysz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/4/539 |
Similar Items
-
In Vitro Inhibition of Zika Virus Replication with Amantadine and Rimantadine Hydrochlorides
by: Jorge L. Arias-Arias, et al.
Published: (2021-09-01) -
Prominent Efficacy of Amantadine against Human Borna Disease Virus Infection In Vitro and In Vivo. Comment on Fink et al. Amantadine Inhibits SARS-CoV-2 In Vitro. <i>Viruses</i> 2021, <i>13</i>, 539
by: Liv Bode, et al.
Published: (2022-02-01) -
Amantadine and Rimantadine Analogues—Single-Crystal Analysis and Anti-Coronaviral Activity
by: Kalina Shishkova, et al.
Published: (2023-09-01) -
Amantadine variant – aryl conjugates that inhibit multiple M2 mutant – amantadine resistant influenza a viruses
by: Christina Tzitzoglaki, et al.
Published: (2022-12-01) -
Amantadine-induced livedo reticularis - Case report
by: Maria Victória Quaresma, et al.
Published: (2015-10-01)